7271 - 7280 of 9034 Results
Title
Year
-
OPENTitle: Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 172End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.019Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996113002659Citation Count: 87
-
OPENTitle: Radiolabeled Aminopyrazoles as Novel Isoform Selective Probes for pJNK3 QuantificationJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 13Issue #: 10Start Page: 1606End Page: 1614Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.2c00278Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9575163Citation Count: 4
- Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's diseaseJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 871Issue #:Start Page: 172914End Page: 172914Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172914Citation Count: 21
-
OPENTitle: Prevalence and Risk Factors for Double Vision in Parkinson DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 709End Page: 712Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13220Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13220Citation Count: 12
- A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease2016RESTRICTEDTitle: A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1373End Page: 1380Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26659Citation Count: 140
-
OPENTitle: Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2539End Page: 2548Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28533Citation Count: 60
- Association between Perceived Dysphagia Symptoms and Swallowing Physiology in Parkinson's Disease2025OPENTitle: Association between Perceived Dysphagia Symptoms and Swallowing Physiology in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 12Issue #: 10Start Page: 1571End Page: 1581Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.70129Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.70129Citation Count: 4
-
OPENTitle: Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 48Issue #:Start Page: 222.e1End Page: 222.e7Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.07.013Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2016.07.013Citation Count: 27
- Lewy bodies are incidental in essential tremor2016RESTRICTEDTitle: Lewy bodies are incidental in essential tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 26Issue #:Start Page: 81End Page: 81Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.02.025Citation Count: 3
-
OPENTitle: Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonismJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s12974-026-03716-3Best OA location URL: https://doi.org/10.1186/s12974-026-03716-3Citation Count: 1